RT Journal Article SR Electronic T1 THERAPEUTIC MAMMOPLASTY AUDIT FROM A SINGLE INSTITUTIONAL COHORT FROM INDIA JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.06.22.21258390 DO 10.1101/2021.06.22.21258390 A1 Chaitanyanand B. Koppiker A1 Nutan Gangurde A1 Santosh Dixit A1 Pragnya Chiguruapati A1 Gautam Sharan A1 Upendra Dhar A1 HariKiran Allampati A1 Laleh Busheri A1 Smeeta Nare A1 Sneha Joshi A1 Sanket Nagarkar YR 2021 UL http://medrxiv.org/content/early/2021/06/28/2021.06.22.21258390.abstract AB Introduction Therapeutic Mammoplasty (TM) is a Oncoplastic Breast Surgery (OBS) technique suitable for medium-to-large breasts with ptosis with large or multifocal/multicentric (MF/MC) tumors. Several studies have indicated that TM expands the scope, extent, and application of breast conservation surgery. This report describes in detail TM outcomes in Indian breast cancer (BC) patients.Methods From our single institutional cohort (n = 211), we present data related to surgical techniques, clinical management, oncological safety, cosmetic and patient reported outcomes (PROMs, based on Breast-Q questionnaire) from BC patients who underwent TM (categorized as simple, complex, extreme and split-reduction type)Results Mean age at diagnosis was 48.7 years. Majority of these patients had advanced stage (II/III) disease. 178 patients consented and 171 completed 1 year follow-up from 3 main groups (a) simple (n=87) (b) complex (n =39) and (c) extreme TM (n = 49). The post-operative complication rates were low (<10%) without any delay in adjuvant treatment. Cosmetic scores were good-to-excellent (n = 154). Post-1-year PROMs (n=149) revealed good-to-excellent score for satisfaction with breast, cosmetic outcome and psychosocial well-being for all TM types.Conclusion Our study is a first detailed report describing a multi-factorial audit in TM single institutional cohort in Indian BC patients. We propose that our TM technique/s may be optimally suited for BC scenarios common in India namely (a) advanced stage BC patients with moderate-to-large breasts with mild/severe ptosis (b) multifocal, multicentric tumors (c) LABC at initial presentation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge Bajaj Auto Ltd. for providing support to research activities at Prashanti Cancer Care Mission, Pune.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Independent Ethics Committee at Prashanti Cancer care Mission. The study was approved by an Independent Ethics Committee (DCDI/CDSCO registration number: ECR/298/Indt/MH/2018). All subjects gave their consent for the use of their personal and medical information including images in the publication of this study. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe study investigators would like to state that all data related to the manuscript will be available for further review on request after consultation with institutional ethics committeesBCBreast CancerBCSBreast Conservation SurgeryBCTBreast Conservation TherapyDCISDuctal Carcinoma In situEOExtreme OncoplastyIDCIntraductal CarcinomaNACNipple Areolar ComplexOBSOncoplastic Breast SurgeryPROMsPatient Reported Outcome MeasuresQoLQuality of LifeRTRadiation TherapySIBSimultaneous Integrated BoostTRMTherapeutic Reduction MammoplastyUOQUpper Outer Quadrant